Companies Dominating the Omeprazole Landscape
- Boehringer Ingelheim
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AstraZeneca Plc.
- Azurity Pharma
- Perrigo Company Plc.
- Salix pharmaceuticals
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of omeprazole is estimated at USD 1.25 billion.
The omeprazole market size was valued at USD 1.13 billion in 2024 and is set to exceed USD 2.56 billion by 2037, expanding at over 6.5% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of gastroesophageal reflux, increasing awareness among people, and increasing prevalence of duodenal ulcers will drive the market growth.
North America industry is set to dominate majority revenue share of 59% by 2037, as the region experienced prevalence of H. pylori infection which causes ulcers.
The major players in the market are Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals, and others.
